What is Shandong Weigao Group Medical Polymer Co PB Ratio?
Shandong Weigao Group Medical Polymer CoSHWGY +6.90%70 PB Ratio is 0.52 as of Jul. 08, 2026, which is 72% below its 10-year median of 1.87. GuruFocus rates SHWGY with a GF Score™ of 70/100 and a GF Value™ of $3.01 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Shandong Weigao Group Medical Polymer Co ranks better than 92.5% on this metric.
SHWGY's PB Ratio is ranked better than 92.5% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs SHWGY: 0.55
During the past 12 months, Shandong Weigao Group Medical Polymer Co's average Book Value Per Share Growth Rate was 5.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 3.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 4.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 8.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Shandong Weigao Group Medical Polymer Co was 66.50% per year. The lowest was 2.30% per year. And the median was 10.60% per year.
Back to Basics: PB Ratio
Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Shandong Weigao Group Medical Polymer Co PB Ratio Related Terms
Shandong Weigao Group Medical Polymer Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co PB Ratio Chart
Shandong Weigao Group Medical Polymer Co Annual Data
For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Group Medical Polymer Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's PB Ratio falls into.
Shandong Weigao Group Medical Polymer Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shandong Weigao Group Medical Polymer Co (SHWGY) has a PB Ratio of 0.52 as of Jul. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. This is 72% below median its historical median of 1.87. Over the past decade, Shandong Weigao Group Medical Polymer Co's PB Ratio has ranged from 0.52 to 5.29. According to the industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #59 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 7.5%.
Is Shandong Weigao Group Medical Polymer Co's PB Ratio too high?
Shandong Weigao Group Medical Polymer Co's current PB Ratio of 0.52 is 72% below median its 10-year median of 1.87. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 5.29. The Medical Devices & Instruments industry median PB Ratio is 2.06. Shandong Weigao Group Medical Polymer Co's value of 0.52 is 74.8% below this industry median. Based on the distribution chart, Shandong Weigao Group Medical Polymer Co ranks #59 out of 787 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #59 out of 787 companies for PB Ratio. This places Shandong Weigao Group Medical Polymer Co in the top 8% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.06. Shandong Weigao Group Medical Polymer Co's value of 0.52 is 74.8% below this benchmark. Historically, Shandong Weigao Group Medical Polymer Co's own PB Ratio has ranged from 0.52 to 5.29 over the past decade. While the company's 10-year median is 1.87 vs. the industry median of 2.06, Shandong Weigao Group Medical Polymer Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.06, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Group Medical Polymer Co's current PB Ratio of 0.52 is 74.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Group Medical Polymer Co's current PB Ratio is 0.52, which is 72% below median its own 10-year median of 1.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.01, compared to a current price of $1.60 — trading 47% below its estimated fair value. The current PB Ratio is 0.52, which is 72% below median its 10-year median of 1.87 and 74.8% below the Medical Devices & Instruments industry median of 2.06. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGY), the current PB Ratio is 0.52 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Group Medical Polymer Co (SHWGY) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued.
The current stock price of $1.60 is trading 47% below its estimated GF Value™ of $3.01.
GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.
Key valuation signals for SHWGY:
PB Ratio: 0.52 (72% below median its 10-year median of 1.87)
GF Value™: $3.01 vs. price of $1.60 (47% below fair value)
Industry Position: 74.8% below the Medical Devices & Instruments median (#59 of 787)
No single metric tells the full story. See the SHWGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Weigao Group Medical Polymer Co Business Description
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
70GF Score
Get the complete analysis for SHWGY
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHWGY has been successfully added to your 
